Korea emerging as global drug trial hub

Published: 2010-07-28 06:59:00

Updated: 2010-07-28 06:59:00

Korea is rapidly emerging as a global hub of clinical trials for multinational firms thanks to its excellent infrastructure for clinical research, the Ministry of Health, Welfare and Family Affairs said on July 25.

“The number of global clinical trials undertaken in Korea under the sponsorship of five multinational companies – AstraZeneca, Pfizer, Sanofi-Aventis, Otsuka and Novartis - surged...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.